STOCK TITAN

Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Allergan Aesthetics (NYSE:ABBV) has launched its Faces of Natrelle® campaign, featuring nine women sharing their personal experiences with breast augmentation and reconstruction using Natrelle® breast implants. The campaign, selected through a nationwide casting call, includes diverse stories from breast cancer survivors, mothers, and professionals who chose breast procedures for various personal reasons.

The initiative aims to increase transparency and understanding around breast procedures, which remain among the most popular cosmetic and reconstructive surgeries in the U.S. Natrelle® offers 300 options with five profiles and three gel types for customized results. The campaign will be featured across social media channels and digital platforms, showcasing real stories of transformation and empowerment.

Allergan Aesthetics (NYSE:ABBV) ha lanciato la campagna Faces of Natrelle®, che presenta nove donne che condividono le loro esperienze personali con l'aumento e la ricostruzione del seno utilizzando gli impianti mammari Natrelle®. La campagna, selezionata tramite un casting nazionale, include storie diverse di sopravvissute al cancro al seno, madri e professioniste che hanno scelto interventi al seno per motivi personali differenti.

L'iniziativa mira ad aumentare la trasparenza e la comprensione riguardo agli interventi al seno, che restano tra le chirurgie estetiche e ricostruttive più diffuse negli Stati Uniti. Natrelle® offre 300 opzioni con cinque profili e tre tipi di gel per risultati personalizzati. La campagna sarà diffusa sui canali social e sulle piattaforme digitali, mostrando storie reali di trasformazione e empowerment.

Allergan Aesthetics (NYSE:ABBV) ha lanzado su campaña Faces of Natrelle®, que presenta a nueve mujeres compartiendo sus experiencias personales con el aumento y la reconstrucción mamaria utilizando implantes Natrelle®. La campaña, seleccionada mediante un casting a nivel nacional, incluye diversas historias de supervivientes de cáncer de mama, madres y profesionales que eligieron procedimientos mamarios por diferentes motivos personales.

La iniciativa busca aumentar la transparencia y el entendimiento sobre los procedimientos mamarios, que siguen siendo de las cirugías estéticas y reconstructivas más populares en EE.UU.. Natrelle® ofrece 300 opciones con cinco perfiles y tres tipos de gel para resultados personalizados. La campaña se difundirá en redes sociales y plataformas digitales, mostrando historias reales de transformación y empoderamiento.

Allergan Aesthetics (NYSE:ABBV)가 Faces of Natrelle® 캠페인을 시작했습니다. 이 캠페인에는 Natrelle® 유방 보형물을 사용한 유방 확대 및 재건 수술 경험을 공유하는 아홉 명의 여성이 등장합니다. 전국 캐스팅을 통해 선정된 이 캠페인은 유방암 생존자, 엄마, 그리고 전문가 등 다양한 배경을 가진 여성들의 개인적인 이야기를 담고 있습니다.

이 캠페인은 미국에서 가장 인기 있는 미용 및 재건 수술 중 하나인 유방 수술에 대한 투명성과 이해를 높이는 것을 목표로 합니다. Natrelle®는 맞춤형 결과를 위해 다섯 가지 프로필과 세 가지 젤 타입을 포함한 300가지 옵션을 제공합니다. 이 캠페인은 소셜 미디어 채널과 디지털 플랫폼을 통해 실제 변화를 보여주는 이야기와 함께 소개될 예정입니다.

Allergan Aesthetics (NYSE:ABBV) a lancé sa campagne Faces of Natrelle®, mettant en avant neuf femmes partageant leurs expériences personnelles d'augmentation et de reconstruction mammaire avec les implants Natrelle®. La campagne, sélectionnée via un casting national, inclut des histoires variées de survivantes du cancer du sein, de mères et de professionnelles ayant choisi des interventions mammaires pour diverses raisons personnelles.

Cette initiative vise à accroître la transparence et la compréhension autour des interventions mammaires, qui restent parmi les chirurgies esthétiques et reconstructrices les plus populaires aux États-Unis. Natrelle® propose 300 options avec cinq profils et trois types de gel pour des résultats personnalisés. La campagne sera diffusée sur les réseaux sociaux et les plateformes digitales, mettant en avant de véritables histoires de transformation et d'empowerment.

Allergan Aesthetics (NYSE:ABBV) hat seine Kampagne Faces of Natrelle® gestartet, in der neun Frauen ihre persönlichen Erfahrungen mit Brustvergrößerung und -rekonstruktion mit Natrelle® Brustimplantaten teilen. Die Kampagne, ausgewählt durch ein landesweites Casting, umfasst vielfältige Geschichten von Brustkrebspatientinnen, Müttern und Berufstätigen, die aus unterschiedlichen persönlichen Gründen Brustoperationen gewählt haben.

Die Initiative zielt darauf ab, mehr Transparenz und Verständnis für Brustoperationen zu schaffen, die zu den beliebtesten kosmetischen und rekonstruktiven Eingriffen in den USA gehören. Natrelle® bietet 300 Optionen mit fünf Profilen und drei Geltypen für individuelle Ergebnisse. Die Kampagne wird auf Social-Media-Kanälen und digitalen Plattformen gezeigt und präsentiert echte Geschichten von Transformation und Empowerment.

Positive
  • Campaign promotes transparency and education about breast procedures
  • Broad product portfolio with 300 implant options
  • Strong focus on patient empowerment and authentic testimonials
Negative
  • Breast implants require ongoing monitoring and potential additional surgeries
  • Risk of complications including BIA-ALCL cancer and systemic symptoms
  • Not lifetime devices - increased risk of complications over time
  • Nine women from across the U.S. share their personal experiences with breast augmentation and reconstruction with Natrelle® – celebrating confidence, self-expression, and restoration.

IRVINE, Calif., Aug. 5, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is launching its Faces of Natrelle® campaign – a powerful tribute to resilience and authenticity. The campaign features nine inspiring women who openly share their breast augmentation and reconstruction journeys with Natrelle® breast implants, aiming to reshape the narrative around breast procedures through real, relatable stories.

Following a nationwide open casting call earlier this year, the selected women represent a wide range of lived experiences – from navigating reconstruction after breast cancer, to reclaiming their body after motherhood, or simply choosing to invest in themselves. United by strength and a renewed sense of self, these women embody the Natrelle® mission: embrace your journey, own your choices, and live your curves.

"Faces of Natrelle® is about more than breast implants – it's about honoring the people behind every decision and every transformation," said Nicole Katz, Vice President, Corporate Affairs & Customer Engagement, Allergan Aesthetics. "Despite being among the most popular cosmetic and reconstructive surgeries in the U.S.1, breast procedures are still often misunderstood. We're proud to spotlight the stories of real women that reflect a growing cultural shift towards transparency and empowerment."

Meet the 2025 Faces of Natrelle®:

  • Andrea R., Patient Care Coordinator
  • Anna W., Founder of Onco-Ballet Foundation and Breast Cancer Survivor
  • Dessiree G., Model and Entrepreneur
  • Heidi W., Veterinarian, Mother, and Workout Enthusiast
  • Leila E., PA, Content Creator and Breast Cancer Survivor
  • Rasha P., Podcaster and Flight Attendant
  • Samantha F., Teacher and Mother
  • Tamika H., Entrepreneur and Author
  • Whitney K., Aesthetician

The Faces of Natrelle® will be featured on the brand's social media channels and all relevant digital platforms. To learn more about the campaign and the women's stories or find information on Natrelle® breast implants, visit www.natrelle.com or follow @NatrelleBreastAugmentation and @NatrelleBreastReconstruction on Instagram, @natrelle on YouTube, and @natrellebreastimplants on TikTok. Natrelle® offers the broadest selection of breast implant options – with 300 options, five profiles, and three gel types – allowing patients and surgeons to achieve their desired look.

Natrelle® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES

Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery.

Breast implants have been associated with the development of a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more commonly in patients with textured breast implants than smooth implants, although rates are not well defined. Some patients have died from BIA-ALCL.

Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others. Individual patient risk for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed without replacement.

Who can get breast implants?
Natrelle® Breast Implants are approved for the following:

  • Breast augmentation for women at least 22 years old for silicone-filled implants and for women at least 18 years old for saline-filled implants. Breast augmentation includes primary breast augmentation to increase the breast size and revision surgery to correct or improve the result of a primary breast augmentation
  • Breast reconstruction. This includes primary breast reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality. This also includes revision surgery to correct or improve the result of a primary breast reconstruction

Who should NOT get breast implants?
Breast implant surgery should NOT be performed in:

  • Women with active infection anywhere in their body
  • Women with existing cancer or precancer of their breast who have not received adequate treatment for those conditions
  • Women who are currently pregnant or nursing

What should I tell my doctor?
Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher:

  • Autoimmune diseases (eg, lupus and scleroderma)
  • A weakened immune system (eg, taking medications to decrease the body's immune response)
  • Planned chemotherapy or radiation therapy following breast implant placement
  • Conditions or medications that interfere with wound healing and blood clotting
  • Reduced blood supply to breast tissue
  • Clinical diagnosis of depression or other mental health disorders, including body dysmorphic disorder and eating disorders
  • Those with a diagnosis of depression or other mental health disorders should wait for resolution or stabilization of these conditions prior to undergoing breast implantation surgery

What else should I consider?

  • There is a Boxed Warning for breast implants. Please see bold text at beginning
  • Many changes to your breasts following implantation are irreversible. If you later choose to have your implants removed and not replaced, you may experience dimpling, puckering, wrinkling, or other cosmetic changes, which may be permanent
  • Breast implantation is likely not a one-time surgery. The longer implants are in place, the greater the potential risk for complications. You will likely need additional surgeries on your breasts due to complications or unacceptable cosmetic results. Thus, you should also consider the complication rates for later (revision) surgery since you may experience these risks in the future
  • Cancer treatments and surgery will affect the outcome and timing of breast reconstruction
  • Breast implants may affect your ability to breastfeed, either by reducing or eliminating milk production
  • Rupture of a silicone-filled breast implant is most often silent. Even if you have no symptoms, you should have your first ultrasound or MRI at 5 to 6 years after your initial implant surgery and then every 2 to 3 years thereafter regardless of whether your implants are for augmentation or reconstruction. If you have symptoms of or uncertain ultrasound results for breast implant rupture, an MRI is recommended. Additional imaging may be required depending on your medical history and status. The health consequences of a ruptured silicone gel-filled breast implant have not been fully established
  • Routine screening mammography for breast cancer will be more difficult, and implants may rupture during the procedure. Perform self-examination every month for cancer screening and ask your surgeon to help you distinguish the implant from your breast tissue. Lumps, persistent pain, swelling, hardening, or changes in implant shape should be reported to your surgeon and possibly evaluated with imaging

What are key complications with breast implants? 
Key complications include reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture (severe scar tissue around the implant). Other complications include breast pain, swelling, asymmetry, wrinkling/rippling, implant malposition nipple complications, hypertrophic scarring, and implant palpability/visibility.

Talk to your doctor about other complications.

For more information, see the patient brochures at www.allergan.com/products.
To report a problem with Natrelle® Breast Implants, please call Allergan® at 1-800-624-4261.

The sale and distribution of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

About Natrelle®
Natrelle® offers a wide range of breast implant options designed with safety, science, and aesthetics in mind. Backed by over 600 published studies and more than 50 years of research and experience, Natrelle® implants provide patients and surgeons with choices to support personalized outcomes.

About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skincare, and more. With cutting-edge science and a deep understanding of patients, we are committed to empowering confidence.

References:

  1. ASPS 2024 Procedural Statistics Release. https://www.plasticsurgery.org/documents/news/statistics/2024/plastic-surgery-statistics-report-2024.pdf.

© 2025 AbbVie. All rights reserved. All trademarks are the property of their respective owners.

Contacts:

Allergan Aesthetics Media:
Ember Garrett
+1 (949) 413-6091
Garrett_ember@allergan.com 

AbbVie Investors:
Liz Shea
+1 (847) 935-2211
Liz.Shea@abbvie.com

 

Meet the 2025 Faces of Natrelle®

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-unveils-the-new-faces-of-natrelle-and-real-stories-of-empowerment-and-transparency-302521116.html

SOURCE AbbVie

FAQ

What is the new Faces of Natrelle® campaign by Allergan Aesthetics (ABBV)?

The campaign features nine real women sharing their personal experiences with Natrelle® breast implants, including breast cancer survivors, mothers, and professionals, aimed at promoting transparency and education about breast procedures.

How many breast implant options does Natrelle® offer?

Natrelle® offers 300 breast implant options with five profiles and three gel types, allowing patients and surgeons to achieve customized results.

What are the main safety concerns with Natrelle® breast implants?

Key safety concerns include the risk of BIA-ALCL (breast implant-associated cancer), potential systemic symptoms, the need for regular monitoring, and possible complications requiring additional surgeries.

Who is eligible for Natrelle® breast implants?

Natrelle® breast implants are approved for women aged 22 and older for silicone-filled implants and 18 and older for saline-filled implants for both augmentation and reconstruction purposes.

What monitoring is required for Natrelle® breast implants?

Patients need their first ultrasound or MRI at 5-6 years after initial surgery, followed by checks every 2-3 years. Additional imaging may be required based on medical history.
Abbvie Inc

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Latest SEC Filings

ABBV Stock Data

344.84B
1.76B
0.11%
74.95%
0.88%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NORTH CHICAGO